Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garret Cullen

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Alimentary Pharmacology & Therapeutics|September 2, 2021
Review Article: vaccination for patients with inflammatory bowel disease during the COVID-19 pandemicJayne Doherty, Sean Fennessy, Roisin Stack, et al.
European Journal of Gastroenterology & Hepatology|May 10, 2007
Intravenous proton pump inhibitor use in hospital practiceEoin Slattery, Ruben Theyventhiran, Garret Cullen, et al.
Gastroenterology Research and Practice|July 28, 2018
Severe Symptomatic Primary CMV Infection in Inflammatory Bowel Disease Patients with Low Population SeroprevalenceCatherine Rowan, Ciaran Judge, Mary D Cannon, et al.
Frontline Gastroenterology|March 15, 2024
Inflammatory Bowel Disease Disability Index is a valid and reliable measure of disability in an English-speaking hospital practice and predicts long-term requirement for treatment escalationDarragh Storan, Edel McDermott, Jenny Moloney, et al.
BMJ Open Gastroenterology|January 31, 2018
Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)Juliette Sheridan, Carol Ann Coe, Peter Doran, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 3, 2014
An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitisDavid J Gibson, Zaid S Heetun, Ciaran E Redmond, et al.
BMJ Open Gastroenterology|September 12, 2023
Implementation of BSG/ACPGBI/PHE polypectomy surveillance guidelines safely reduces the burden of surveillance in a screening cohort: a virtual model studyRoisin Stack, Jayne Doherty, Neil O'Moráin, et al.
Frontline Gastroenterology|September 25, 2018
A prospective study of faecal immunochemical testing following polypectomy in a colorectal cancer screening populationDavid J Gibson, Blathnaid Nolan, Joanna Rea, et al.
Gastroenterology|November 20, 2018
Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel DiseasesBrona Wynne, Louise McHugh, Wei Gao, et al.
Journal of Gastrointestinal Cancer|April 3, 2015
Visceral Adiposity is a Risk Factor for Poor Prognosis in Colorectal Cancer Patients Receiving Adjuvant ChemotherapyChun Seng Lee, David J Murphy, Colm McMahon, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Alimentary Pharmacology & Therapeutics|September 2, 2021
Review Article: vaccination for patients with inflammatory bowel disease during the COVID-19 pandemicJayne Doherty, Sean Fennessy, Roisin Stack, et al.
European Journal of Gastroenterology & Hepatology|May 10, 2007
Intravenous proton pump inhibitor use in hospital practiceEoin Slattery, Ruben Theyventhiran, Garret Cullen, et al.
Gastroenterology Research and Practice|July 28, 2018
Severe Symptomatic Primary CMV Infection in Inflammatory Bowel Disease Patients with Low Population SeroprevalenceCatherine Rowan, Ciaran Judge, Mary D Cannon, et al.
Frontline Gastroenterology|March 15, 2024
Inflammatory Bowel Disease Disability Index is a valid and reliable measure of disability in an English-speaking hospital practice and predicts long-term requirement for treatment escalationDarragh Storan, Edel McDermott, Jenny Moloney, et al.
BMJ Open Gastroenterology|January 31, 2018
Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)Juliette Sheridan, Carol Ann Coe, Peter Doran, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 3, 2014
An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitisDavid J Gibson, Zaid S Heetun, Ciaran E Redmond, et al.
BMJ Open Gastroenterology|September 12, 2023
Implementation of BSG/ACPGBI/PHE polypectomy surveillance guidelines safely reduces the burden of surveillance in a screening cohort: a virtual model studyRoisin Stack, Jayne Doherty, Neil O'Moráin, et al.
Frontline Gastroenterology|September 25, 2018
A prospective study of faecal immunochemical testing following polypectomy in a colorectal cancer screening populationDavid J Gibson, Blathnaid Nolan, Joanna Rea, et al.
Gastroenterology|November 20, 2018
Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel DiseasesBrona Wynne, Louise McHugh, Wei Gao, et al.
Journal of Gastrointestinal Cancer|April 3, 2015
Visceral Adiposity is a Risk Factor for Poor Prognosis in Colorectal Cancer Patients Receiving Adjuvant ChemotherapyChun Seng Lee, David J Murphy, Colm McMahon, et al.
Pageof 7